IMR Press / CEOG / Volume 42 / Issue 6 / DOI: 10.12891/ceog1999.2015

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Case Report
Early operative treatment of anti-N-methyl D-aspartate (anti-NMDA) receptor encephalitis in a patient with ovarian teratoma
Show Less
1 Department of Obstetrics and Gynecology, Osaka City University, Graduate School of Medicine, Osaka (Japan)
Clin. Exp. Obstet. Gynecol. 2015, 42(6), 819–821; https://doi.org/10.12891/ceog1999.2015
Published: 10 December 2015
Abstract

Background: Anti-N-methyl D-aspartate (anti-NMDA) receptor encephalitis is often accompanied by ovarian teratoma. Early tumor resection is reported to be effective as a treatment. Case: A 21-year-old woman presented with anti-NMDA receptor encephalitis which was accompanied by ovarian teratoma. The present case was a very rare case of an early stage of anti-NMDA receptor encephalitis receiving operative treatment before confirming the presence of anti-NMDA receptor antibody. The diagnosis was established postoperatively by identifying anti-NMDA receptor antibody. Conclusion: In case of suspecting anti-NMDA receptor encephalitis in a patient with ovarian teratoma, early operative treatment should be considered even before confirming the presence of anti-NMDA receptor antibody.
Keywords
Anti-NMDA receptor encephalitis
Ovarian teratoma
Share
Back to top